Top MarketRank™ StocksTop MarketRank™NASDAQ:BRKR Bruker (BRKR) Stock Price, News & Analysis $66.81 +2.58 (+4.02%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$64.66▼$67.3150-Day Range$61.21▼$78.2952-Week Range$53.79▼$94.86Volume1.23 million shsAverage Volume1.01 million shsMarket Capitalization$9.71 billionP/E Ratio24.29Dividend Yield0.30%Price Target$81.78 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Bruker alerts: Email Address Bruker MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.56 Rating ScoreUpside/Downside22.4% Upside$81.78 Price TargetShort InterestHealthy2.98% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainability-1.48Upright™ Environmental ScoreNews Sentiment0.56Based on 17 Articles This WeekInsider TradingN/AProj. Earnings Growth18.05%From $2.66 to $3.14 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.98 out of 5 starsComputer And Technology Sector2nd out of 612 stocksAnalytical Instruments Industry1st out of 27 stocks 3.3 Analyst's Opinion Consensus RatingBruker has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 6 buy ratings, 2 hold ratings, and 1 sell rating.Amount of Analyst CoverageBruker has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Bruker's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.98% of the float of Bruker has been sold short.Short Interest Ratio / Days to CoverBruker has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Bruker has recently decreased by 13.03%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend YieldBruker has a dividend yield of 0.31%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBruker does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Bruker is 7.27%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Bruker will have a dividend payout ratio of 6.37% next year. This indicates that Bruker will be able to sustain or increase its dividend.Read more about Bruker's dividend. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreBruker has received a 49.23% net impact score from Upright. Bruker seems to create the most significant positive value in categories "Taxes", "Jobs", and "Creating knowledge". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Biological hazard detectors", "Nuclear radiation detectors", and "Material x-ray scanners" products. See details.Environmental SustainabilityThe Environmental Impact score for Bruker is -1.48. Previous Next 2.5 News and Social Media Coverage News SentimentBruker has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Bruker this week, compared to 6 articles on an average week.MarketBeat Follows5 people have added Bruker to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Bruker insiders have not sold or bought any company stock.Percentage Held by Insiders28.30% of the stock of Bruker is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions79.52% of the stock of Bruker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Bruker's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Bruker are expected to grow by 18.05% in the coming year, from $2.66 to $3.14 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bruker is 24.29, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.95.Price to Earnings Ratio vs. SectorThe P/E ratio of Bruker is 24.29, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 253.64.Price to Earnings Growth RatioBruker has a PEG Ratio of 2.24. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBruker has a P/B Ratio of 6.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Bruker's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Bruker Stock (NASDAQ:BRKR)Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.Read More BRKR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BRKR Stock News HeadlinesJuly 22, 2024 | americanbankingnews.comLeerink Partnrs Brokers Boost Earnings Estimates for Bruker Co. (NASDAQ:BRKR)July 20, 2024 | americanbankingnews.comResearch Analysts Set Expectations for Bruker Co.'s Q1 2026 Earnings (NASDAQ:BRKR)July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.July 20, 2024 | americanbankingnews.comQ2 2024 Earnings Forecast for Bruker Co. (NASDAQ:BRKR) Issued By Zacks ResearchJuly 19, 2024 | au.finance.yahoo.comBruker Corporation (B2RK34.SA)July 19, 2024 | finance.yahoo.comBruker Announces that Injunction Impacting NanoString’s CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective ImmediatelyJuly 19, 2024 | americanbankingnews.comZacks Research Weighs in on Bruker Co.'s FY2024 Earnings (NASDAQ:BRKR)July 17, 2024 | investorplace.com7 Quantum Computing Stocks That Could Be Multibaggers in the Making: July EditionJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.June 25, 2024 | businesswire.comCellens Announces Collaboration with Bruker BioAFM to Advance Mechanobiology Technology for Cancer DetectionJune 3, 2024 | businesswire.comBruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied LaboratoriesJune 3, 2024 | businesswire.comBruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) ApplicationsJune 3, 2024 | businesswire.comBruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular ProteomicsMay 31, 2024 | seekingalpha.comBruker: A Confusing Acquisition SpreeMay 31, 2024 | businesswire.comBruker Corporation to Present at Upcoming Investor ConferencesMay 29, 2024 | businesswire.comBruker Announces Pricing of Public Offering of Common StockMay 29, 2024 | businesswire.comBruker Announces Public Offering of Common StockMay 23, 2024 | finance.yahoo.comIs Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?See More Headlines Receive BRKR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Ex-Dividend for 6/17 Dividend6/03/2024Dividend Payable6/17/2024Today7/26/2024Next Earnings (Estimated)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:BRKR CUSIP11679410 CIK1109354 Webwww.bruker.com Phone(978) 663-3660Fax978-663-5585Employees9,707Year Founded1960Price Target and Rating Average Stock Price Target$81.78 High Stock Price Target$102.00 Low Stock Price Target$60.00 Potential Upside/Downside+22.4%Consensus RatingModerate Buy Rating Score (0-4)2.56 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$2.75 Trailing P/E Ratio24.29 Forward P/E Ratio25.12 P/E Growth2.24Net Income$427.20 million Net Margins13.38% Pretax Margin16.97% Return on Equity27.31% Return on Assets8.82% Debt Debt-to-Equity Ratio0.95 Current Ratio1.81 Quick Ratio0.91 Sales & Book Value Annual Sales$2.96 billion Price / Sales3.28 Cash Flow$3.73 per share Price / Cash Flow17.93 Book Value$10.08 per share Price / Book6.63Miscellaneous Outstanding Shares145,340,000Free Float104,205,000Market Cap$9.71 billion OptionableOptionable Beta1.20 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Gerald N. Herman (Age 66)Executive VP & CFO Comp: $1.13MDr. Mark R. Munch Ph.D. (Age 62)Corporate Executive VP and President of Bruker Nano Group & Corporate Comp: $1.63MMr. Juergen Srega (Age 69)President of Bruker CALID Group & Bruker Daltonics Division Comp: $842.19kDr. Falko Busse Ph.D. (Age 57)President of Bruker BioSpin Group Comp: $945.18kDr. Frank H. Laukien Ph.D. (Age 64)Chairman, CEO & President Comp: $1.82MMr. Justin Joseph WardSenior Director of Investor Relations & Corporate DevelopmentMr. J. Brent Alldredge J.D. (Age 49)General Counsel & Secretary Stacey DesrochersTreasurer & Director of Investor RelationsDr. Burkhard Prause Ph.D. (Age 57)President and CEO of Bruker Energy & Supercon Technologies, Inc. Comp: $595.96kMore ExecutivesKey CompetitorsRevvityNYSE:PKIBerkeley LightsNASDAQ:BLIMettler-Toledo InternationalNYSE:MTDIlluminaNASDAQ:ILMNWatersNYSE:WATView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 27,870 shares on 7/26/2024Ownership: 0.665%Allspring Global Investments Holdings LLCBought 74,541 shares on 7/26/2024Ownership: 0.096%State of Michigan Retirement SystemBought 700 shares on 7/26/2024Ownership: 0.016%Retirement Systems of AlabamaBought 3,734 shares on 7/24/2024Ownership: 0.083%Louisiana State Employees Retirement SystemBought 800 shares on 7/24/2024Ownership: 0.019%View All Insider TransactionsView All Institutional Transactions BRKR Stock Analysis - Frequently Asked Questions How have BRKR shares performed this year? Bruker's stock was trading at $73.48 at the beginning of 2024. Since then, BRKR shares have decreased by 9.1% and is now trading at $66.81. View the best growth stocks for 2024 here. How were Bruker's earnings last quarter? Bruker Co. (NASDAQ:BRKR) issued its quarterly earnings results on Thursday, May, 2nd. The medical research company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.07. The company's quarterly revenue was up 5.3% on a year-over-year basis. What is Frank H. Laukien's approval rating as Bruker's CEO? 126 employees have rated Bruker Chief Executive Officer Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among the company's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend. Does Bruker have any subsidiaries? Bruker subsidiaries include PMOD Technologies, Arxspan, Alicona Imaging, JPK Instruments, Luxendo, Hysitron, InVivo Biotech Services GmbH, and others. Who are Bruker's major shareholders? Top institutional investors of Bruker include Pallas Capital Advisors LLC (6.52%), Bank of New York Mellon Corp (0.66%), Vaughan Nelson Investment Management L.P. (0.41%) and Assenagon Asset Management S.A. (0.14%). Insiders that own company stock include Frank H Laukien, Richard A Packer, Gerald N Herman, Hermann Fritz Requardt, Cynthia M Friend, Marc A Kastner and Mark Munch. View institutional ownership trends. How do I buy shares of Bruker? Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Bruker own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA) and Walt Disney (DIS). This page (NASDAQ:BRKR) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bruker Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bruker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
